Cellebrite DI Ltd.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash and cash equivalents $128.7m $146.0m $87.6m $189.5m $191.7m $124.5m
Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively) $66.3m $67.5m $78.8m $77.3m $82.4m $105.0m
Prepaid expenses and other current assets $7.4m $12.8m $17.1m $26.4m $23.2m $19.6m
Inventories $4.8m $6.5m $10.2m $9.9m $8.9m $7.6m
Total current assets $324.3m $273.2m $295.9m $422.1m $567.6m $575.9m
Property and equipment, net $16.1m $16.8m $17.3m $15.9m $17.0m $22.2m
Intangible assets, net $6.6m $11.2m $11.3m $10.6m $11.3m $81.5m
Goodwill $9.5m $26.8m $26.8m $26.8m $28.7m $119.6m
Operating Lease, Right-of-Use Asset $0 $15.7m $14.3m $10.6m $16.3m
Short-term deposits $108.9m $35.6m $51.3m $74.7m $153.7m $161.0m
Marketable securities $0 $22.1m $28.9m $36.6m $98.0m
Contract acquisition costs $3.0m $4.8m $6.3m $5.5m $5.8m $6.6m
Other non-current assets $565k $2.0m $1.7m $7.3m $7.7m $14.6m
Deferred tax assets, net $7.4m $9.8m $12.5m $7.0m $11.1m $10.9m
Trade payables $4.7m $9.5m $4.6m $8.3m $11.1m $16.8m
Deferred revenues $33.4m $36.4m $42.2m $47.1m $45.2m $49.5m
Operating lease liabilities $0 $10.4m $9.2m $6.8m $18.7m
Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively 0 0 0 0 0
Total non-current assets $40.1m $66.6m $107.4m $110.8m $123.0m $363.0m
Total long-term liabilities $40.0m $226.6m $121.7m $244.8m $59.0m $84.9m
Total Shareholders’ equity $63.8m ($73.3m) $73.9m $34.2m $336.0m $484.3m
Total assets $364.4m $339.8m $403.3m $532.9m $690.6m $938.9m
Other accounts payable and accrued expenses $49.1m $54.0m $45.5m $44.8m $63.3m $71.2m
Total current liabilities $159.4m $186.6m $207.8m $253.8m $295.5m $369.7m
Other long-term liabilities $6.2m $9.2m $5.4m $5.5m $7.0m $16.7m
Total liabilities $199.4m $413.1m $329.4m $498.7m $354.5m $454.5m
Additional paid-in capital $34.2m ($153.1m) ($125.6m) ($84.9m) $498.9m $568.7m
Common stock par value per share (in NIS per share) $0.00 $0.00 $0.00 $0.00
Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares ($85k) ($85k) ($85k) ($85k) ($85k) ($85k)
Accumulated Other Comprehensive Income (Loss), Net of Tax $1.3m $1.4m $331k $1.1m $2.1m $2.2m
Accumulated deficit $28.3m $78.4m $199.2m $118.1m ($164.9m) ($86.5m)
Total liabilities and shareholders’ equity $364.4m $339.8m $403.3m $532.9m $690.6m $938.9m